ALFUZOSIN HYDROCHLORIDE

ALFUZOSIN HYDROCHLORIDE was reported 2470 times

ALFUZOSIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MINIMUM INHIBITORY CONCENTRATION 16 0.4848
1 HMG COA REDUCTASE ANTIBODY TEST 6 0.3333
2 LEPTOMENINGEAL MYELOMATOSIS 2 0.1538
3 MINIMUM INHIBITORY CONCENTRATION INCREASED 3 0.1500
4 ACHILLES TENDON DISCOMFORT 1 0.1111
5 CAMPYLOBACTER TEST POSITIVE 6 0.0789
6 GROWTH HORMONE DEFICIENCY 26 0.0655
7 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 19 0.0615
8 BRAIN STEM HAEMATOMA 2 0.0435
9 PARAMNESIA 3 0.0380
10 CROWNED DENS SYNDROME 1 0.0323
11 PSEUDOFOLLICULITIS 2 0.0317
12 BLADDER TRANSITIONAL CELL CARCINOMA STAGE III 1 0.0256
13 DRUG DISPENSED TO WRONG PATIENT 23 0.0241
14 PYELITIS 4 0.0192
15 PITUITARY TUMOUR BENIGN 27 0.0165
16 ASPIRATION BONE MARROW ABNORMAL 2 0.0148
17 HYPOTENSIVE CRISIS 2 0.0139
18 PROSTATISM 2 0.0136
19 THROMBOSIS MESENTERIC VESSEL 3 0.0131
20 AUTOIMMUNE MYOSITIS 6 0.0127
21 BLADDER STENOSIS 1 0.0122
22 GASTROENTERITIS ESCHERICHIA COLI 6 0.0110
23 CSF GLUCOSE INCREASED 1 0.0104
24 INTERSTITIAL GRANULOMATOUS DERMATITIS 2 0.0104
25 FAECAL VOMITING 5 0.0094
26 ALLERGY TO ANIMAL 10 0.0094
27 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
28 ABDOMINAL REBOUND TENDERNESS 1 0.0089
29 COLD FLASH 1 0.0086
30 WRONG PATIENT RECEIVED PRODUCT 25 0.0085
31 CEREBRAL MICROANGIOPATHY 2 0.0084
32 AORTIC INTRAMURAL HAEMATOMA 1 0.0077
33 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 3 0.0074
34 THERAPEUTIC RESPONSE DELAYED 19 0.0068
35 SMALL FIBRE NEUROPATHY 5 0.0068
36 STEROID DIABETES 10 0.0067
37 RETROGRADE EJACULATION 5 0.0063
38 PROSTATIC HAEMORRHAGE 2 0.0063
39 CHOLELITHIASIS OBSTRUCTIVE 1 0.0060
40 HYPERLIPASAEMIA 3 0.0057
41 BLOOD PROLACTIN DECREASED 1 0.0057
42 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 5 0.0056
43 DIVERTICULITIS INTESTINAL PERFORATED 2 0.0056
44 CARDIOVASCULAR INSUFFICIENCY 9 0.0055
45 MANUFACTURING MATERIALS ISSUE 2 0.0050
46 CORPORA CAVERNOSA SURGERY 1 0.0050
47 BRAIN NATRIURETIC PEPTIDE ABNORMAL 1 0.0047
48 LICHENOID KERATOSIS 10 0.0044
49 PRODUCT SHAPE ISSUE 4 0.0042
50 DEVICE INTOLERANCE 1 0.0042
51 BIOPSY SKIN ABNORMAL 1 0.0042
52 CERVICAL MYELOPATHY 1 0.0041
53 NORMOCYTIC ANAEMIA 6 0.0041
54 CYTOMEGALOVIRUS TEST POSITIVE 7 0.0039
55 DYSPNOEA AT REST 11 0.0038
56 BACTERIAL ENDOPHTHALMITIS 1 0.0038
57 WRONG PRODUCT ADMINISTERED 25 0.0037
58 PSEUDOLYMPHOMA 2 0.0036
59 ABDOMINAL WALL HAEMATOMA 7 0.0036
60 INTRACRANIAL HAEMATOMA 2 0.0036
61 BIOPSY KIDNEY 1 0.0035
62 CAMPYLOBACTER GASTROENTERITIS 2 0.0034
63 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 2 0.0033
64 HEPATIC CYTOLYSIS 42 0.0033
65 DECREASED EYE CONTACT 1 0.0033
66 DISORGANISED SPEECH 6 0.0033
67 BRADYARRHYTHMIA 5 0.0030
68 HYPOVITAMINOSIS 4 0.0030
69 CAROTID ARTERY ANEURYSM 1 0.0029
70 HEPATITIS CHOLESTATIC 17 0.0028
71 STREPTOCOCCAL BACTERAEMIA 3 0.0028
72 COLOUR BLINDNESS ACQUIRED 1 0.0028
73 CENTRAL OBESITY 2 0.0027
74 ACETABULUM FRACTURE 1 0.0027
75 BRADYPNOEA 7 0.0026
76 AMYOTROPHY 1 0.0026
77 MYCOPLASMA INFECTION 2 0.0026
78 CLUBBING 1 0.0025
79 DELUSIONAL PERCEPTION 1 0.0024
80 CARDITIS 1 0.0024
81 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
82 TESTICULAR ATROPHY 2 0.0023
83 PURPURA 20 0.0023
84 FOREIGN BODY IN THROAT 7 0.0022
85 TRAUMATIC INTRACRANIAL HAEMORRHAGE 2 0.0022
86 BUNDLE BRANCH BLOCK 2 0.0021
87 COLITIS MICROSCOPIC 10 0.0021
88 CEREBRAL HAEMATOMA 7 0.0021
89 BLINDNESS CORTICAL 1 0.0020
90 CELL DEATH 4 0.0020
91 URINARY TRACT INFECTION BACTERIAL 5 0.0020
92 BREAST CANCER MALE 1 0.0020
93 CAPILLARY FRAGILITY 1 0.0020
94 BRAIN NEOPLASM BENIGN 1 0.0020
95 PNEUMONIA PSEUDOMONAL 3 0.0020
96 RESPIRATORY TRACT IRRITATION 2 0.0019
97 CUTANEOUS VASCULITIS 7 0.0019
98 ANALGESIC DRUG LEVEL INCREASED 3 0.0019
99 BODY FAT DISORDER 1 0.0018
100 ANORGASMIA 5 0.0018
101 CHOLESTASIS 35 0.0018
102 CYTOLYTIC HEPATITIS 6 0.0018
103 NEUROPATHY 3 0.0018
104 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 18 0.0018
105 FLAT AFFECT 4 0.0017
106 HYPOCHLORAEMIA 2 0.0017
107 OXYGEN CONSUMPTION INCREASED 4 0.0017
108 MIXED LIVER INJURY 5 0.0017
109 PROSTATIC OPERATION 2 0.0017
110 DYSENTERY 3 0.0016
111 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
112 DERMATOSIS 1 0.0016
113 HEPATIC NECROSIS 6 0.0016
114 HYPERAESTHESIA TEETH 2 0.0016
115 BLOOD PARATHYROID HORMONE ABNORMAL 1 0.0016
116 HYPERVENTILATION 9 0.0016
117 IATROGENIC INJURY 2 0.0016
118 TONIC CLONIC MOVEMENTS 2 0.0015
119 CYTOMEGALOVIRUS CHORIORETINITIS 3 0.0015
120 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
121 HYPERSENSITIVITY VASCULITIS 4 0.0015
122 HYPERLACTACIDAEMIA 4 0.0015
123 PRODUCT ADMINISTRATION ERROR 30 0.0015
124 HYPOVOLAEMIC SHOCK 7 0.0015
125 PERITONEAL HAEMORRHAGE 2 0.0014
126 MICROCYTIC ANAEMIA 3 0.0014
127 SUBILEUS 3 0.0014
128 HYPERPHOSPHATAEMIA 3 0.0014
129 CHOLESTATIC LIVER INJURY 3 0.0013
130 CORNEAL DEPOSITS 1 0.0013
131 PANCREATITIS ACUTE 30 0.0013
132 BRAIN STEM SYNDROME 1 0.0013
133 HAEMORRHAGIC TRANSFORMATION STROKE 2 0.0013
134 PROSTATITIS 4 0.0013
135 ORAL MUCOSAL ERUPTION 2 0.0013
136 DAYDREAMING 2 0.0013
137 TOXIC SKIN ERUPTION 13 0.0013
138 GASTRITIS EROSIVE 6 0.0013
139 ASEPTIC NECROSIS BONE 1 0.0013
140 POISONING DELIBERATE 12 0.0013
141 PNEUMONIA LEGIONELLA 2 0.0012
142 ACUTE PULMONARY OEDEMA 7 0.0012
143 MUSCLE HAEMORRHAGE 5 0.0012
144 LEUKOCYTOCLASTIC VASCULITIS 2 0.0012
145 ALLERGIC GRANULOMATOUS ANGIITIS 1 0.0012
146 CSF PROTEIN INCREASED 1 0.0012
147 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
148 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
149 HYPERKALAEMIA 41 0.0012
150 CRANIOFACIAL FRACTURE 1 0.0012
151 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
152 DEFAECATION URGENCY 8 0.0011
153 AGRANULOCYTOSIS 21 0.0011
154 BLOOD PHOSPHORUS INCREASED 3 0.0011
155 SUBDURAL HAEMORRHAGE 3 0.0011
156 BRAIN STEM HAEMORRHAGE 1 0.0011
157 PRODUCT DISPENSING ERROR 23 0.0011
158 MICTURITION URGENCY 12 0.0010
159 OPTIC ISCHAEMIC NEUROPATHY 4 0.0010
160 DIZZINESS POSTURAL 10 0.0010
161 IMMUNOSUPPRESSION 9 0.0010
162 DEVICE SAFETY FEATURE ISSUE 1 0.0010
163 ANTISOCIAL BEHAVIOUR 1 0.0010
164 METABOLIC ENCEPHALOPATHY 3 0.0010
165 REBOUND ATOPIC DERMATITIS 2 0.0010
166 HICCUPS 8 0.0010
167 HYPERURICAEMIA 4 0.0010
168 BLADDER DYSFUNCTION 1 0.0010
169 BREAST DISCOMFORT 1 0.0010
170 BURNS THIRD DEGREE 1 0.0009
171 ASTERIXIS 1 0.0009
172 ANAEMIA MACROCYTIC 2 0.0009
173 CEREBRAL ARTERY OCCLUSION 1 0.0009
174 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
175 BLADDER DILATATION 1 0.0009
176 ACARODERMATITIS 1 0.0009
177 HYPERKERATOSIS 5 0.0009
178 ON AND OFF PHENOMENON 5 0.0009
179 FAECES PALE 2 0.0009
180 TONGUE BLISTERING 2 0.0009
181 CATHETER SITE DISCHARGE 1 0.0009
182 ANAL INCONTINENCE 8 0.0009
183 URINARY TRACT DISORDER 4 0.0009
184 CORTISOL DECREASED 1 0.0009
185 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
186 MIOSIS 7 0.0009
187 AORTIC STENOSIS 3 0.0009
188 DILATATION ATRIAL 1 0.0009
189 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 2 0.0009
190 SINUS OPERATION 2 0.0008
191 URINARY RETENTION 28 0.0008
192 COCCIDIOIDOMYCOSIS 1 0.0008
193 URINE FLOW DECREASED 2 0.0008
194 HYPONATRAEMIA 47 0.0008
195 CHRONIC RESPIRATORY FAILURE 1 0.0008
196 SINUS BRADYCARDIA 8 0.0008
197 STARING 2 0.0008
198 PSEUDOMONAS INFECTION 7 0.0008
199 BLOOD UREA DECREASED 1 0.0008
200 RETINAL ARTERY OCCLUSION 2 0.0008
201 TOXIC ENCEPHALOPATHY 4 0.0008
202 COMA 37 0.0008
203 MEDICATION RESIDUE 2 0.0008
204 BLOOD CHLORIDE DECREASED 2 0.0008
205 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
206 VENTRICULAR DYSFUNCTION 2 0.0008
207 RHINOVIRUS INFECTION 3 0.0008
208 ACTINIC KERATOSIS 2 0.0008
209 VENTRICULAR EXTRASYSTOLES 8 0.0008
210 ABDOMINAL OPERATION 1 0.0008
211 PROSTATOMEGALY 3 0.0008
212 RADICULOPATHY 2 0.0008
213 PRODUCT RESIDUE PRESENT 4 0.0007
214 ERECTILE DYSFUNCTION 19 0.0007
215 BEHAVIOUR DISORDER 4 0.0007
216 ALTERED STATE OF CONSCIOUSNESS 16 0.0007
217 PERIPHERAL VENOUS DISEASE 3 0.0007
218 CALCULUS BLADDER 1 0.0007
219 ANAPHYLACTOID REACTION 3 0.0007
220 HEMIPLEGIA 6 0.0007
221 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
222 DRUG TOLERANCE DECREASED 2 0.0007
223 APPENDIX DISORDER 1 0.0007
224 FEBRILE BONE MARROW APLASIA 3 0.0007
225 HEPATOCELLULAR INJURY 10 0.0007
226 INJECTION SITE SCAR 2 0.0007
227 CEREBELLAR HAEMORRHAGE 1 0.0007
228 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
229 HYPERTONIC BLADDER 2 0.0007
230 HYPOTHERMIA 7 0.0007
231 HAEMOTHORAX 2 0.0007
232 ORTHOSTATIC HYPOTENSION 12 0.0007
233 FAECES SOFT 5 0.0007
234 BILIARY COLIC 2 0.0007
235 PNEUMONIA ASPIRATION 17 0.0007
236 LACTIC ACIDOSIS 22 0.0007
237 APRAXIA 1 0.0007
238 RASH MACULO-PAPULAR 15 0.0007
239 PHOTOSENSITIVITY REACTION 11 0.0007
240 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
241 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
242 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
243 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
244 RENAL FAILURE CHRONIC 5 0.0006
245 THERAPY NON-RESPONDER 29 0.0006
246 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
247 DRUG INTERACTION 102 0.0006
248 BONE MARROW FAILURE 13 0.0006
249 EXPIRED PRODUCT ADMINISTERED 21 0.0006
250 BRONCHOSPASM 9 0.0006
251 POLYMYALGIA RHEUMATICA 2 0.0006
252 SKIN EROSION 2 0.0006
253 AORTIC VALVE DISEASE 1 0.0006
254 HEPATITIS ACUTE 4 0.0006
255 ACUTE KIDNEY INJURY 94 0.0006
256 DENTAL IMPLANTATION 1 0.0006
257 BLADDER DISORDER 6 0.0006
258 FLUID INTAKE REDUCED 3 0.0006
259 DERMATITIS EXFOLIATIVE 3 0.0006
260 DEMENTIA ALZHEIMER'S TYPE 1 0.0006
261 POTENTIATING DRUG INTERACTION 2 0.0006
262 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
263 LOWER RESPIRATORY TRACT INFECTION 27 0.0006
264 B-CELL LYMPHOMA 2 0.0006
265 PETIT MAL EPILEPSY 3 0.0006
266 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
267 DYSPNOEA EXERTIONAL 22 0.0006
268 HAEMATURIA 20 0.0006
269 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
270 BLOOD CHLORIDE INCREASED 1 0.0006
271 LYMPHOEDEMA 4 0.0006
272 SKIN NECROSIS 3 0.0006
273 PRESYNCOPE 14 0.0006
274 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
275 HANGOVER 2 0.0006
276 TUMOUR LYSIS SYNDROME 5 0.0006
277 TYPE I HYPERSENSITIVITY 2 0.0006
278 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
279 VERTIGO 34 0.0006
280 HYDROCEPHALUS 3 0.0006
281 CONTRAST MEDIA ALLERGY 1 0.0005
282 HYPOPHOSPHATAEMIA 4 0.0005
283 FREEZING PHENOMENON 2 0.0005
284 HYPERTENSIVE CRISIS 6 0.0005
285 THINKING ABNORMAL 10 0.0005
286 BLADDER SPASM 1 0.0005
287 ADENOCARCINOMA OF COLON 1 0.0005
288 PROTEIN TOTAL DECREASED 2 0.0005
289 PEMPHIGOID 4 0.0005
290 SNORING 2 0.0005
291 FACE INJURY 2 0.0005
292 TONGUE OEDEMA 2 0.0005
293 HYPERTHERMIA 4 0.0005
294 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
295 HALLUCINATION, VISUAL 11 0.0005
296 MULTI-ORGAN FAILURE 9 0.0005
297 CARDIOPULMONARY FAILURE 2 0.0005
298 APLASIA 1 0.0005
299 BICYTOPENIA 1 0.0005
300 PRODUCT USE COMPLAINT 8 0.0005
301 ISCHAEMIC STROKE 9 0.0005
302 HOT FLUSH 38 0.0005
303 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
304 SEASONAL ALLERGY 7 0.0005
305 HALLUCINATION 37 0.0005
306 EXTRAVASATION 2 0.0005
307 BLOOD CREATINE PHOSPHOKINASE INCREASED 14 0.0005
308 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
309 DISORIENTATION 19 0.0005
310 DILATATION VENTRICULAR 1 0.0005
311 HYPOCALCAEMIA 9 0.0005
312 DEVICE CONNECTION ISSUE 1 0.0005
313 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
314 HYPERPYREXIA 2 0.0005
315 BUNDLE BRANCH BLOCK LEFT 2 0.0005
316 BRADYCARDIA 25 0.0005
317 FOREIGN BODY SENSATION IN EYES 3 0.0005
318 HEPATITIS 12 0.0005
319 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
320 INFUSION SITE PAIN 6 0.0005
321 DEREALISATION 1 0.0005
322 PRODUCT COMMUNICATION ISSUE 4 0.0005
323 GINGIVAL SWELLING 2 0.0005
324 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
325 CARDIAC FAILURE ACUTE 3 0.0004
326 TOOTH DISORDER 10 0.0004
327 BACTERIAL TEST POSITIVE 1 0.0004
328 CEREBRAL HAEMORRHAGE 16 0.0004
329 ADENOCARCINOMA 1 0.0004
330 MYOSITIS 4 0.0004
331 COLITIS ISCHAEMIC 3 0.0004
332 STATUS EPILEPTICUS 5 0.0004
333 URINE ABNORMALITY 2 0.0004
334 RENAL FUNCTION TEST ABNORMAL 2 0.0004
335 DRUG LEVEL INCREASED 7 0.0004
336 SPUTUM DISCOLOURED 4 0.0004
337 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
338 MYOCLONUS 5 0.0004
339 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
340 CARDIOGENIC SHOCK 6 0.0004
341 DERMATITIS BULLOUS 3 0.0004
342 BRONCHITIS CHRONIC 1 0.0004
343 RENAL TUBULAR NECROSIS 4 0.0004
344 DYSURIA 15 0.0004
345 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
346 STEVENS-JOHNSON SYNDROME 9 0.0004
347 ARTHROPOD BITE 3 0.0004
348 HYPERVOLAEMIA 2 0.0004
349 DIABETIC NEUROPATHY 2 0.0004
350 DEVICE INFUSION ISSUE 1 0.0004
351 ATRIAL FIBRILLATION 39 0.0004
352 CYTOKINE RELEASE SYNDROME 8 0.0004
353 MUSCLE ATROPHY 5 0.0004
354 CORONARY ARTERIAL STENT INSERTION 2 0.0004
355 APPENDICITIS PERFORATED 1 0.0004
356 CANCER PAIN 1 0.0004
357 FEMORAL NECK FRACTURE 2 0.0004
358 ENDOCARDITIS 2 0.0004
359 UNRESPONSIVE TO STIMULI 10 0.0004
360 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
361 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
362 CATATONIA 2 0.0004
363 INCONTINENCE 4 0.0004
364 RETCHING 8 0.0004
365 BLOOD DISORDER 3 0.0004
366 INTESTINAL OBSTRUCTION 14 0.0004
367 URINARY INCONTINENCE 11 0.0004
368 MUSCLE TIGHTNESS 6 0.0004
369 HYPOTENSION 74 0.0004
370 AGITATION 27 0.0004
371 CLUMSINESS 1 0.0004
372 POLYURIA 3 0.0004
373 PULMONARY FIBROSIS 7 0.0004
374 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
375 PROSTATIC DISORDER 2 0.0004
376 EXTRAPYRAMIDAL DISORDER 9 0.0004
377 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
378 DIABETIC COMA 1 0.0004
379 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
380 PRODUCTIVE COUGH 17 0.0004
381 SKIN PLAQUE 3 0.0004
382 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
383 SUBDURAL HAEMATOMA 5 0.0003
384 THROMBOCYTOPENIA 39 0.0003
385 ANURIA 3 0.0003
386 MYOPATHY 3 0.0003
387 MUSCLE STRAIN 3 0.0003
388 HYPOKALAEMIA 16 0.0003
389 CONFUSIONAL STATE 56 0.0003
390 PYELONEPHRITIS 3 0.0003
391 DEVICE POWER SOURCE ISSUE 1 0.0003
392 HYPOVOLAEMIA 2 0.0003
393 GROIN PAIN 3 0.0003
394 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
395 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
396 COVID-19 PNEUMONIA 4 0.0003
397 GOUT 6 0.0003
398 PROTHROMBIN TIME PROLONGED 2 0.0003
399 RESPIRATORY DISORDER 10 0.0003
400 CENTRAL VENOUS CATHETERISATION 1 0.0003
401 CRANIOCEREBRAL INJURY 1 0.0003
402 NOCTURIA 4 0.0003
403 PNEUMONIA BACTERIAL 3 0.0003
404 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
405 DIASTOLIC DYSFUNCTION 1 0.0003
406 TENDONITIS 5 0.0003
407 OLIGURIA 2 0.0003
408 DELUSION 5 0.0003
409 OXYGEN SATURATION DECREASED 18 0.0003
410 BLOOD CREATININE DECREASED 1 0.0003
411 BLOOD URINE PRESENT 6 0.0003
412 BILE DUCT STONE 1 0.0003
413 ACUTE RESPIRATORY FAILURE 6 0.0003
414 POLLAKIURIA 13 0.0003
415 CARDIO-RESPIRATORY ARREST 13 0.0003
416 HERNIA 6 0.0003
417 HYPOGLYCAEMIA 15 0.0003
418 INCOHERENT 2 0.0003
419 DIPLOPIA 8 0.0003
420 ANGINA UNSTABLE 2 0.0003
421 VITAMIN D DEFICIENCY 3 0.0003
422 BREAST ENLARGEMENT 1 0.0003
423 PULMONARY CONGESTION 4 0.0003
424 WALKING AID USER 2 0.0003
425 SALIVARY HYPERSECRETION 3 0.0003
426 SYNCOPE 30 0.0003
427 BREAST MASS 2 0.0003
428 JAUNDICE 8 0.0003
429 BK VIRUS INFECTION 1 0.0003
430 BLOOD BILIRUBIN INCREASED 8 0.0003
431 PRODUCT SUBSTITUTION ISSUE 17 0.0003
432 PALLOR 8 0.0003
433 ECCHYMOSIS 2 0.0003
434 DIFFICULTY IN WALKING 1 0.0003
435 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
436 AUTOIMMUNE HEPATITIS 2 0.0003
437 FORMICATION 2 0.0003
438 GASTROINTESTINAL HAEMORRHAGE 24 0.0003
439 EXTRASYSTOLES 2 0.0003
440 ENCEPHALOPATHY 7 0.0003
441 APPLICATION SITE REACTION 2 0.0003
442 DUODENAL ULCER 2 0.0003
443 SINUS TACHYCARDIA 4 0.0003
444 APPENDICECTOMY 1 0.0003
445 RECTAL HAEMORRHAGE 12 0.0003
446 LIVER FUNCTION TEST ABNORMAL 8 0.0003
447 OESOPHAGITIS 3 0.0003
448 PRODUCT STORAGE ERROR 24 0.0003
449 CAROTID ARTERY OCCLUSION 1 0.0003
450 NEUTROPENIA 37 0.0003
451 HEPATOTOXICITY 6 0.0003
452 INTERSTITIAL LUNG DISEASE 13 0.0003
453 MALNUTRITION 3 0.0003
454 BACTERIAL INFECTION 5 0.0003
455 BREAST TENDERNESS 2 0.0003
456 COLITIS 10 0.0003
457 SCAB 3 0.0003
458 PLEURAL EFFUSION 16 0.0003
459 OEDEMA PERIPHERAL 32 0.0003
460 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
461 CARDIAC FAILURE 21 0.0003
462 COMMUNICATION DISORDER 1 0.0003
463 DISSOCIATION 2 0.0003
464 POST PROCEDURAL COMPLICATION 5 0.0003
465 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
466 PERICARDIAL EFFUSION 6 0.0003
467 RENAL FAILURE ACUTE 11 0.0003
468 VASCULITIS 3 0.0003
469 PELVIC FRACTURE 2 0.0003
470 HAEMORRHAGIC STROKE 2 0.0003
471 SEXUAL DYSFUNCTION 3 0.0003
472 PULMONARY HAEMORRHAGE 2 0.0003
473 FLUID RETENTION 13 0.0003
474 MULTIPLE ALLERGIES 2 0.0003
475 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
476 BACTERAEMIA 3 0.0003
477 MOOD SWINGS 8 0.0003
478 CEREBRAL ATROPHY 1 0.0003
479 DEMENTIA 7 0.0003
480 ARTERIOSPASM CORONARY 1 0.0002
481 SENSORY DISTURBANCE 4 0.0002
482 STENT PLACEMENT 2 0.0002
483 PRODUCT PHYSICAL ISSUE 5 0.0002
484 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
485 MUSCLE DISORDER 2 0.0002
486 URINARY TRACT INFECTION 42 0.0002
487 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
488 ACUTE CORONARY SYNDROME 2 0.0002
489 BLOOD PRESSURE DECREASED 16 0.0002
490 PULMONARY HYPERTENSION 5 0.0002
491 RHABDOMYOLYSIS 10 0.0002
492 HAEMODIALYSIS 2 0.0002
493 PERICARDITIS 4 0.0002
494 INFUSION SITE ERYTHEMA 2 0.0002
495 AORTIC VALVE INCOMPETENCE 1 0.0002
496 CIRCULATORY COLLAPSE 4 0.0002
497 ANAPHYLACTIC SHOCK 6 0.0002
498 ARRHYTHMIA 11 0.0002
499 HAEMATOMA 6 0.0002
500 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
501 DELIRIUM 8 0.0002
502 RESPIRATORY TRACT INFECTION 6 0.0002
503 DISCOMFORT 14 0.0002
504 INTENTIONAL PRODUCT MISUSE 20 0.0002
505 EOSINOPHILIA 4 0.0002
506 MELAENA 5 0.0002
507 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
508 MALIGNANT MELANOMA 3 0.0002
509 SNEEZING 5 0.0002
510 FREQUENT BOWEL MOVEMENTS 6 0.0002
511 SINUS CONGESTION 3 0.0002
512 ANAEMIA 42 0.0002
513 AGGRESSION 11 0.0002
514 PRODUCT AVAILABILITY ISSUE 5 0.0002
515 FALL 73 0.0002
516 NEPHROLITHIASIS 10 0.0002
517 TINNITUS 10 0.0002
518 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
519 PRODUCT DISTRIBUTION ISSUE 2 0.0002
520 HAEMOPTYSIS 6 0.0002
521 PANCYTOPENIA 12 0.0002
522 APPENDICITIS 2 0.0002
523 PHOTOPHOBIA 4 0.0002
524 DYSARTHRIA 8 0.0002
525 MYALGIA 36 0.0002
526 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
527 CARDIAC TAMPONADE 1 0.0002
528 ECZEMA 11 0.0002
529 FEELING JITTERY 4 0.0002
530 SLEEP APNOEA SYNDROME 4 0.0002
531 HYPERTHYROIDISM 3 0.0002
532 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
533 SEPTIC SHOCK 9 0.0002
534 GASTROENTERITIS 3 0.0002
535 PARKINSONISM 2 0.0002
536 CHOKING 4 0.0002
537 SURGERY 12 0.0002
538 DISTURBANCE IN ATTENTION 11 0.0002
539 HEPATOMEGALY 2 0.0002
540 BODY TEMPERATURE DECREASED 2 0.0002
541 HOSPICE CARE 2 0.0002
542 SKIN HAEMORRHAGE 3 0.0002
543 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
544 ABDOMINAL TENDERNESS 1 0.0002
545 IMMUNODEFICIENCY 3 0.0002
546 RHINORRHOEA 13 0.0002
547 AGEUSIA 5 0.0002
548 HYPOTONIA 2 0.0002
549 LEUKOPENIA 10 0.0002
550 HEART RATE DECREASED 7 0.0002
551 SOMNOLENCE 40 0.0002
552 MOTOR DYSFUNCTION 2 0.0002
553 RENAL FAILURE 26 0.0002
554 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
555 SKIN ULCER 5 0.0002
556 HYPERBILIRUBINAEMIA 2 0.0002
557 EXPOSURE VIA SKIN CONTACT 5 0.0002
558 ASTHENIA 72 0.0002
559 ACCIDENTAL OVERDOSE 7 0.0002
560 SKIN EXFOLIATION 16 0.0002
561 FULL BLOOD COUNT ABNORMAL 2 0.0002
562 SUDDEN DEATH 2 0.0002
563 HALLUCINATION, AUDITORY 3 0.0002
564 CHILLS 22 0.0002
565 HYPERHIDROSIS 24 0.0002
566 POOR QUALITY SLEEP 4 0.0002
567 BALANCE DISORDER 16 0.0002
568 SKIN LACERATION 2 0.0002
569 PNEUMONITIS 5 0.0002
570 PULMONARY THROMBOSIS 2 0.0002
571 GASTROINTESTINAL PAIN 2 0.0002
572 DEAFNESS UNILATERAL 1 0.0002
573 SUICIDE ATTEMPT 11 0.0002
574 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
575 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
576 CYSTIC FIBROSIS 1 0.0002
577 COAGULOPATHY 3 0.0002
578 DEHYDRATION 24 0.0002
579 EYE PAIN 10 0.0002
580 ASTHMA 20 0.0002
581 CHOLECYSTITIS ACUTE 1 0.0002
582 DERMATITIS CONTACT 2 0.0002
583 SUICIDAL IDEATION 16 0.0002
584 SHOCK 4 0.0002
585 CORONARY ARTERY BYPASS 1 0.0002
586 GASTRIC HAEMORRHAGE 2 0.0002
587 BLOOD URIC ACID INCREASED 1 0.0002
588 BLINDNESS 7 0.0002
589 RENAL DISORDER 8 0.0002
590 DYSSTASIA 5 0.0002
591 COLD SWEAT 3 0.0002
592 PNEUMONIA 55 0.0002
593 CONSTIPATION 37 0.0002
594 DECREASED INTEREST 1 0.0002
595 BRADYKINESIA 1 0.0002
596 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
597 BLOOD IRON DECREASED 2 0.0002
598 DYSPNOEA 95 0.0002
599 CARDIAC PACEMAKER INSERTION 1 0.0002
600 COUGH 47 0.0002
601 GASTROINTESTINAL DISORDER 15 0.0002
602 WRIST FRACTURE 2 0.0002
603 DIZZINESS 82 0.0002
604 RESTLESSNESS 6 0.0002
605 EPILEPSY 5 0.0002
606 CYTOPENIA 2 0.0002
607 HYPOACUSIS 7 0.0002
608 SMALL INTESTINAL OBSTRUCTION 2 0.0002
609 SPINAL OPERATION 2 0.0002
610 TENDON RUPTURE 2 0.0002
611 HYPERCALCAEMIA 2 0.0002
612 CONJUNCTIVITIS 3 0.0002
613 GYNAECOMASTIA 5 0.0002
614 LIMB DISCOMFORT 5 0.0002
615 SEPSIS 18 0.0002
616 CHOLANGITIS 1 0.0002
617 TOOTH EXTRACTION 2 0.0002
618 MIDDLE INSOMNIA 3 0.0002
619 DRUG-INDUCED LIVER INJURY 5 0.0002
620 CELLULITIS 8 0.0002
621 HEAD INJURY 5 0.0002
622 INTRAOCULAR PRESSURE INCREASED 2 0.0002
623 HYPOPHAGIA 4 0.0002
624 PULMONARY OEDEMA 7 0.0002
625 THROAT IRRITATION 7 0.0002
626 INTENTIONAL OVERDOSE 10 0.0002
627 MYDRIASIS 2 0.0002
628 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
629 NIGHT SWEATS 5 0.0002
630 CARDIAC FLUTTER 1 0.0002
631 HIATUS HERNIA 2 0.0002
632 DEEP VEIN THROMBOSIS 10 0.0002
633 DYSPHONIA 9 0.0002
634 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
635 BRADYPHRENIA 1 0.0002
636 MUCOSAL INFLAMMATION 4 0.0002
637 MUSCLE SPASMS 28 0.0002
638 INFLUENZA 17 0.0002
639 IMPAIRED HEALING 5 0.0002
640 SOPOR 2 0.0002
641 APPETITE DISORDER 1 0.0002
642 ERYTHEMA 31 0.0002
643 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
644 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
645 JOINT RANGE OF MOTION DECREASED 2 0.0001
646 INTENTIONAL SELF-INJURY 3 0.0001
647 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
648 DRY MOUTH 12 0.0001
649 TASTE DISORDER 3 0.0001
650 RASH PRURITIC 8 0.0001
651 GINGIVAL BLEEDING 2 0.0001
652 ACUTE HEPATIC FAILURE 2 0.0001
653 PRODUCT DOSE OMISSION ISSUE 43 0.0001
654 RIB FRACTURE 3 0.0001
655 CORONARY ARTERY OCCLUSION 2 0.0001
656 SKIN LESION 4 0.0001
657 PERIPHERAL COLDNESS 2 0.0001
658 ABNORMAL DREAMS 4 0.0001
659 COORDINATION ABNORMAL 2 0.0001
660 RASH MACULAR 5 0.0001
661 RENAL IMPAIRMENT 12 0.0001
662 KNEE ARTHROPLASTY 3 0.0001
663 BLOOD TEST ABNORMAL 2 0.0001
664 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
665 SKIN REACTION 2 0.0001
666 LOSS OF CONSCIOUSNESS 18 0.0001
667 JOINT INJURY 3 0.0001
668 ANGINA PECTORIS 4 0.0001
669 HYPERSOMNIA 4 0.0001
670 EYE IRRITATION 8 0.0001
671 MYELODYSPLASTIC SYNDROME 2 0.0001
672 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
673 HYPERGLYCAEMIA 5 0.0001
674 DYSPHAGIA 13 0.0001
675 PROSTATE CANCER 11 0.0001
676 NEUROPATHY PERIPHERAL 13 0.0001
677 PALPITATIONS 16 0.0001
678 NASAL CONGESTION 8 0.0001
679 BLINDNESS TRANSIENT 1 0.0001
680 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
681 OVERDOSE 29 0.0001
682 COLON CANCER 2 0.0001
683 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
684 RASH PAPULAR 3 0.0001
685 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
686 CARDIAC ARREST 11 0.0001
687 CHROMATURIA 3 0.0001
688 DERMATITIS ATOPIC 7 0.0001
689 DEPRESSED MOOD 7 0.0001
690 LACRIMATION INCREASED 4 0.0001
691 ACIDOSIS 1 0.0001
692 MUSCULOSKELETAL CHEST PAIN 2 0.0001
693 CONCUSSION 1 0.0001
694 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
695 APHTHOUS ULCER 1 0.0001
696 LUNG INFECTION 2 0.0001
697 BLOOD CHOLESTEROL INCREASED 6 0.0001
698 BASAL CELL CARCINOMA 2 0.0001
699 SWOLLEN TONGUE 4 0.0001
700 BRAIN FOG 2 0.0001
701 DISEASE RECURRENCE 6 0.0001
702 RESPIRATORY TRACT CONGESTION 2 0.0001
703 MUSCULOSKELETAL STIFFNESS 11 0.0001
704 DIARRHOEA 81 0.0001
705 SCIATICA 2 0.0001
706 GAIT DISTURBANCE 24 0.0001
707 ATRIAL FLUTTER 1 0.0001
708 METABOLIC ACIDOSIS 4 0.0001
709 HIP FRACTURE 4 0.0001
710 HAEMORRHAGE 13 0.0001
711 FLATULENCE 7 0.0001
712 BLOOD POTASSIUM INCREASED 2 0.0001
713 CEREBRAL INFARCTION 3 0.0001
714 DECUBITUS ULCER 1 0.0001
715 ASPHYXIA 1 0.0001
716 CONVULSION 7 0.0001
717 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 22 0.0001
718 ABNORMAL FAECES 1 0.0001
719 CHOLELITHIASIS 4 0.0001
720 BRONCHITIS 9 0.0001
721 MANIA 2 0.0001
722 HEART RATE INCREASED 12 0.0001
723 OFF LABEL USE 106 0.0001
724 EPISTAXIS 9 0.0001
725 INSOMNIA 32 0.0001
726 LIP SWELLING 4 0.0001
727 GAIT INABILITY 4 0.0001
728 FATIGUE 93 0.0001
729 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
730 HAEMATEMESIS 3 0.0001
731 HEMIPARESIS 2 0.0001
732 SINUSITIS 12 0.0001
733 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
734 HAEMOGLOBIN DECREASED 12 0.0001
735 SCAR 2 0.0001
736 MALAISE 51 0.0001
737 DECREASED APPETITE 27 0.0001
738 BLOOD MAGNESIUM DECREASED 1 0.0001
739 PULMONARY EMBOLISM 11 0.0001
740 SPEECH DISORDER 6 0.0001
741 PANCREATITIS 6 0.0001
742 ANGIOEDEMA 5 0.0001
743 VISUAL IMPAIRMENT 14 0.0001
744 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
745 SEIZURE 13 0.0001
746 ABDOMINAL PAIN UPPER 23 0.0001
747 WEIGHT DECREASED 31 0.0001
748 GASTROENTERITIS VIRAL 2 0.0001
749 LEUKOCYTOSIS 2 0.0001
750 RESTLESS LEGS SYNDROME 2 0.0001
751 C-REACTIVE PROTEIN INCREASED 4 0.0001
752 PYREXIA 38 0.0001
753 RESPIRATORY FAILURE 8 0.0001
754 RESPIRATORY ARREST 3 0.0001
755 SKIN DISCOLOURATION 5 0.0001
756 TREMOR 18 0.0001
757 COVID-19 19 0.0001
758 PROCEDURAL PAIN 3 0.0001
759 DRUG ABUSE 9 0.0001
760 NECK PAIN 6 0.0001
761 ABDOMINAL DISCOMFORT 18 0.0001
762 BLOOD CREATININE INCREASED 7 0.0001
763 SWELLING 10 0.0001
764 PRURITUS 41 0.0001
765 MUSCULAR WEAKNESS 12 0.0001
766 FEBRILE NEUTROPENIA 7 0.0001
767 FOOT FRACTURE 2 0.0001
768 OCULAR HYPERAEMIA 5 0.0001
769 GASTRIC ULCER 2 0.0001
770 PROTEINURIA 2 0.0001
771 MUSCULOSKELETAL DISORDER 2 0.0001
772 BLOOD PRESSURE INCREASED 16 0.0001
773 RASH ERYTHEMATOUS 5 0.0001
774 HERPES ZOSTER 6 0.0001
775 DRUG PRESCRIBING ERROR 2 0.0001
776 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
777 DYSTONIA 2 0.0001
778 BONE PAIN 6 0.0001
779 PAIN IN EXTREMITY 30 0.0001
780 ACUTE MYOCARDIAL INFARCTION 3 0.0001
781 WHEEZING 6 0.0001
782 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
783 SINUS DISORDER 2 0.0001
784 ADVERSE DRUG REACTION 9 0.0001
785 DRY EYE 5 0.0001
786 SLEEP DISORDER 7 0.0001
787 CORONARY ARTERY DISEASE 3 0.0001
788 EXTRA DOSE ADMINISTERED 4 0.0001
789 FEEDING DISORDER 2 0.0001
790 BODY TEMPERATURE INCREASED 2 0.0001
791 FEELING HOT 6 0.0001
792 PERIPHERAL SWELLING 15 0.0001
793 PRODUCT PREPARATION ERROR 2 0.0001
794 DRUG INEFFECTIVE 128 0.0001
795 DEPRESSION 22 0.0001
796 INCORRECT DOSE ADMINISTERED 22 0.0001
797 BACK PAIN 22 0.0001
798 VISION BLURRED 13 0.0001
799 HYPERTENSION 20 0.0001
800 HYPOTHYROIDISM 3 0.0001
801 EATING DISORDER 2 0.0001
802 WEIGHT INCREASED 21 0.0001
803 BREAST PAIN 1 0.0001
804 BODY HEIGHT DECREASED 1 0.0001
805 CONTUSION 9 0.0001
806 SKIN CANCER 2 0.0001
807 DECREASED ACTIVITY 1 0.0001
808 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
809 BACK INJURY 1 0.0001
810 DIABETES MELLITUS 7 0.0001
811 ARTHRALGIA 38 0.0001
812 ASPIRATION 1 0.0001
813 BLOOD GLUCOSE FLUCTUATION 1 0.0001
814 HAEMATOCHEZIA 5 0.0001
815 DENTAL CARIES 1 0.0001
816 MEDICATION ERROR 5 0.0001
817 URTICARIA 15 0.0001
818 GLOSSODYNIA 2 0.0001
819 BLISTER 5 0.0001
820 CONDITION AGGRAVATED 27 0.0001
821 FLUSHING 9 0.0001
822 LETHARGY 5 0.0001
823 MUSCLE TWITCHING 2 0.0001
824 CHEST PAIN 16 0.0001
825 MYOCARDIAL INFARCTION 15 0.0001
826 BLADDER CANCER 5 0.0001
827 LYMPHADENOPATHY 3 0.0001
828 HEADACHE 53 0.0001
829 THERAPY INTERRUPTED 6 0.0001
830 CHOLECYSTITIS 1 0.0001
831 FEELING ABNORMAL 20 0.0001
832 BLOOD PRESSURE FLUCTUATION 2 0.0001
833 IRRITABILITY 5 0.0001
834 THERAPEUTIC RESPONSE DECREASED 5 0.0001
835 BURSITIS 1 0.0001
836 ADRENAL INSUFFICIENCY 1 0.0001
837 FIBROMYALGIA 2 0.0001
838 NEURALGIA 2 0.0001
839 ABDOMINAL PAIN 19 0.0001
840 LUNG DISORDER 4 0.0001
841 LIVER INJURY 2 0.0001
842 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
843 CARDIOMEGALY 1 0.0001
844 INJECTION SITE MASS 3 0.0001
845 CYST 1 0.0001
846 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
847 DERMATITIS ALLERGIC 1 0.0001
848 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
849 ABDOMINAL PAIN LOWER 2 0.0001
850 CHEST DISCOMFORT 8 0.0001
851 ANOREXIA 1 0.0001
852 AMNESIA 5 0.0001
853 SWELLING FACE 5 0.0001
854 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
855 GASTRITIS 2 0.0001
856 RASH 33 0.0001
857 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
858 PLATELET COUNT DECREASED 8 0.0001
859 INJECTION SITE PAIN 23 0.0001
860 CARDIAC DISORDER 7 0.0001
861 PRODUCT USE ISSUE 14 0.0001
862 VOMITING 35 0.0001
863 FEAR 2 0.0001
864 BLOOD GLUCOSE INCREASED 14 0.0001
865 THROAT TIGHTNESS 2 0.0001
866 DYSKINESIA 3 0.0001
867 LIMB INJURY 2 0.0001
868 PRODUCT QUALITY ISSUE 10 0.0001
869 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
870 RESPIRATORY DISTRESS 2 0.0001
871 DIVERTICULITIS 2 0.0001
872 FEELING COLD 2 0.0001
873 ROAD TRAFFIC ACCIDENT 3 0.0001
874 HOSPITALISATION 11 0.0001
875 WOUND 2 0.0001
876 BURNING SENSATION 5 0.0001
877 DEVICE OCCLUSION 1 0.0001
878 BLINDNESS UNILATERAL 1 0.0001
879 OSTEOARTHRITIS 3 0.0001
880 NASOPHARYNGITIS 13 0.0001
881 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
882 INTENTIONAL DOSE OMISSION 2 0.0001
883 RED BLOOD CELL COUNT DECREASED 2 0.0001
884 DEVICE LEAKAGE 3 0.0001
885 INFECTION 10 0.0001
886 APATHY 1 0.0001
887 ASCITES 2 0.0001
888 ILLNESS 7 0.0001
889 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
890 PSYCHOTIC DISORDER 2 0.0001
891 CATARACT 4 0.0001
892 ABDOMINAL DISTENSION 7 0.0001
893 HYPOAESTHESIA 10 0.0001
894 ANXIETY 19 0.0001
895 DEATH 57 0.0001
896 NAUSEA 52 0.0001
897 INJECTION SITE SWELLING 5 0.0001
898 INJECTION SITE RASH 2 0.0001
899 DEVICE RELATED INFECTION 1 0.0001
900 EMOTIONAL DISORDER 2 0.0001
901 OROPHARYNGEAL PAIN 6 0.0001
902 COGNITIVE DISORDER 3 0.0001
903 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
904 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
905 CYANOSIS 1 0.0001
906 MULTIPLE SCLEROSIS 3 0.0001
907 ABSCESS 1 0.0001
908 DYSPEPSIA 6 0.0001
909 STAPHYLOCOCCAL INFECTION 2 0.0001
910 PAIN 37 0.0001
911 VISUAL ACUITY REDUCED 2 0.0001
912 BLOOD UREA INCREASED 1 0.0001
913 EYE PRURITUS 2 0.0001
914 CANDIDA INFECTION 1 0.0001
915 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
916 ANGER 2 0.0001
917 INFLAMMATION 3 0.0001
918 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
919 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
920 DRUG EFFECT DECREASED 3 0.0001
921 OEDEMA 3 0.0001
922 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
923 ARTHROPATHY 3 0.0001
924 DYSGEUSIA 4 0.0001
925 HEPATIC FUNCTION ABNORMAL 2 0.0001
926 TOXICITY TO VARIOUS AGENTS 9 0.0001
927 PLASMA CELL MYELOMA 2 0.0001
928 ARTHRITIS 4 0.0001
929 ABNORMAL BEHAVIOUR 2 0.0001
930 BLOOD PRESSURE ABNORMAL 1 0.0001
931 THROMBOSIS 4 0.0000
932 DEVICE BREAKAGE 2 0.0000
933 LUNG NEOPLASM MALIGNANT 2 0.0000
934 INFLUENZA LIKE ILLNESS 4 0.0000
935 DERMATITIS 1 0.0000
936 WITHDRAWAL SYNDROME 2 0.0000
937 INFUSION RELATED REACTION 3 0.0000
938 DRY SKIN 6 0.0000
939 NEOPLASM MALIGNANT 3 0.0000
940 INJECTION SITE PRURITUS 3 0.0000
941 RHEUMATOID ARTHRITIS 5 0.0000
942 HEPATIC ENZYME INCREASED 3 0.0000
943 HYPERSENSITIVITY 8 0.0000
944 DISEASE PROGRESSION 5 0.0000
945 MOBILITY DECREASED 3 0.0000
946 DRUG INTOLERANCE 4 0.0000
947 CEREBROVASCULAR ACCIDENT 7 0.0000
948 ALOPECIA 8 0.0000
949 ABASIA 1 0.0000
950 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
951 UNEVALUABLE EVENT 3 0.0000
952 THERAPY CESSATION 2 0.0000
953 MUSCULOSKELETAL PAIN 2 0.0000
954 APPLICATION SITE ERYTHEMA 1 0.0000
955 INJECTION SITE HAEMORRHAGE 3 0.0000
956 CARDIAC FAILURE CONGESTIVE 3 0.0000
957 TREATMENT NONCOMPLIANCE 2 0.0000
958 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
959 ANAPHYLACTIC REACTION 2 0.0000
960 TACHYCARDIA 3 0.0000
961 DEVICE ISSUE 3 0.0000
962 BLOOD POTASSIUM DECREASED 1 0.0000
963 JOINT SWELLING 4 0.0000
964 STOMATITIS 2 0.0000
965 PARAESTHESIA 5 0.0000
966 MIGRAINE 3 0.0000
967 CYSTITIS 1 0.0000
968 DEVICE DIFFICULT TO USE 2 0.0000
969 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
970 DEVICE MALFUNCTION 2 0.0000
971 SKIN BURNING SENSATION 2 0.0000
972 UNDERDOSE 2 0.0000
973 ACNE 2 0.0000
974 CHRONIC KIDNEY DISEASE 2 0.0000
975 DRUG DOSE OMISSION BY DEVICE 2 0.0000
976 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
977 DEVICE DISLOCATION 1 0.0000
978 DRUG WITHDRAWAL SYNDROME 2 0.0000
979 COLITIS ULCERATIVE 1 0.0000
980 MEMORY IMPAIRMENT 3 0.0000
981 COLORECTAL CANCER 1 0.0000
982 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
983 DRUG DOSE OMISSION 3 0.0000
984 NO ADVERSE EVENT 3 0.0000
985 PSORIASIS 2 0.0000
986 COMPLETED SUICIDE 1 0.0000
987 ADVERSE EVENT 1 0.0000
988 BREAST CANCER 1 0.0000